No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Howard M. Ross MD: New Chair of Surgery/Surgeon-in-Chief Hackensack University Medical Center and Hackensack Meridian School of Medicine

Editor: What To Know

  • , nationally recognized Colon and Rectal Surgeon, is the new Chair of Surgery/Surgeon-in-Chief of Hackensack University Medical Center, and as Professor and Chair of the Department of Surgery at Hackensack Meridian School of Medicine.
  • He completed his general surgery residency at the University of Connecticut in Hartford, Connecticut, and his colon and rectal surgery residency at Lahey Clinic in Burlington, Massachusetts.
  • Ross is a fellow of the American Society of Colon and Rectal Surgeons, and the American College of Surgeons.

Howard M. Ross, M.D., nationally recognized Colon and Rectal Surgeon, is the new Chair of Surgery/Surgeon-in-Chief of Hackensack University Medical Center, and as Professor and Chair of the Department of Surgery at Hackensack Meridian School of Medicine.

With more than 20 years of experience as a board-certified colon and rectal surgeon, Howard M. Ross, MD specializes in minimally invasive surgical approaches to treating colon and rectal cancer.

Dr. Ross also provides leading-edge surgical care for ulcerative colitis, Crohn’s disease, polyps, and other colorectal conditions. His research interests include the adoption of new technologies, surgical outcomes, surgical education and health disparities.

Dr. Ross is broadly published and the editor of four noted textbooks, including Robotic Approaches to Colorectal Surgery & Minimally Invasive Approaches to Colon and Rectal Disease.

Before his appointments at Hackensack University Medical Center and Hackensack Meridian School of Medicine, Dr. Ross served in various roles at Temple University Health System, Meridian Health System, and University of Pennsylvania Health System.

Most recently he was Vice Chair, Department of Surgery; Professor and Chief, Division of Colon and Rectal Surgery; and Program Director for the General Surgery Residency at Temple University Health System.

As Chair of Surgery/Surgeon-in-Chief, Dr. Ross will oversee 9 Divisions of Surgery that include Bariatrics; Breast; Colorectal; General Surgery; Pediatrics; Surgical Oncology; Thoracic Surgery; Transplant; and Trauma taking place in 18 regular operating room suites; 4 pediatric OR suites; 2 Hybrid OR suites; 3 plastic & reconstructive surgery OR suites; and 12 suites in our Center for Ambulatory Surgery.

Additionally, Dr. Ross will preside over 24 state-of-the-art operating rooms to be housed in the new Helena Theurer Pavilion opening on the campus of Hackensack Meridian Hackensack University Medical Center in 2022.

“We are excited to welcome Dr. Ross in his new leadership role,” said Mark Sparta, FACHE, president and chief hospital executive, Hackensack University Medical Center. “His expertise and years of experience will be a tremendous asset to Hackensack University Medical Center and the community we serve.”

Dr. Ross earned his medical degree from the University of Rochester School of Medicine in Rochester, New York. He completed his general surgery residency at the University of Connecticut in Hartford, Connecticut, and his colon and rectal surgery residency at Lahey Clinic in Burlington, Massachusetts. He completed his surgical oncology research fellowship at Memorial Sloan-Kettering Cancer Center in New York, New York.

“The appointment of Dr. Ross is a significant addition to our group of specialists,” said Lisa Tank, M.D., chief medical officer, Hackensack Meridian Hackensack University Medical Center. “We are excited about his plans to continue to build and expand all of our surgical programs, especially Transplant, Trauma and Colorectal surgery through new techniques and cutting-edge technology.”

As Chair of Surgery/Surgeon-in-Chief Dr. Ross will actively guide the surgical education of future physicians, teaching the art and science of surgery to our residents and medical students.

“Dr. Ross’s reputation precedes him,” said Bonita Stanton, M.D., the founding dean of the Hackensack Meridian School of Medicine. “His contributions to our growing School promise to be invaluable.”

Dr. Ross is a fellow of the American Society of Colon and Rectal Surgeons, and the American College of Surgeons.  He has served as president of the Philadelphia Academy of Surgery and the New Jersey Society of Colon and Rectal Surgery.   Dr. Ross has received numerous honors, including Top Doctor recognitions, Physician of the Year from the Crohn’s and Colitis Foundation, and multiple student and resident teaching awards.

“I am thrilled to join the team at Hackensack University Medical Center’s renowned Department of Surgery, and I look forward to working with each of my colleagues to provide collaborative, high-quality care for our patients,” said Dr. Ross.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy